Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Investments
Malaysian company BioValence recently won the Innovation Award at the Aquaculture Innovation Summit 2017 in London for its RetroMAD1 antiviral protein. But what else has the company got planned for other candidates in its pipeline? Animal Pharm analyst Sian Lazell spoke to the firm to find out more.
Southeast Asian country Vietnam will produce its own vaccines against two common strains of avian influenza, according to local media.
Using insects as a nutritious and cost effective feed in aquaculture has not always been flavor of the month. Following regulatory changes the sector is now becoming a commercial reality. Animal Pharm analyst Malcolm Flanagan talks to Antoine Hubert, the chief executive of Ynsect, about the prospects for the firm and the nascent industry.
Belgian company ViroVet has added another €1.5 million ($1.76 million) to its working capital after completing the second closing of its series A financing round.
US veterinary distributor MWI Animal Health is to pump cash into a start-up specializing in treatment of arthritis and rheumatoid conditions in companion animals.
Phytogenics is a term increasingly cropping up on the radar of animal health, as more firms turn to R&D in natural products. Animal Pharm analyst Sian Lazell spoke to US firm ZIVO Bioscience about how it is using algae to develop a pipeline of bioactive product candidates.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.